| For: | Manganis CD, Chapman RW, Culver EL. Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol 2020; 26(23): 3126-3144 [PMID: 32684731 DOI: 10.3748/wjg.v26.i23.3126] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i23/3126.htm |
| Number | Citing Articles |
| 1 |
Abdullgabbar M Hamid, Sultan A Alshoabi, Abdulkhaleq A Binnuhaid, Kamal Alsultan, Amel F Alzain, Abdulmannan M Aman. Primary Sclerosing Cholangitis Associated With Ulcerative Colitis Coexisting With Cholangiocarcinoma: A Case Report. Cureus 2024; doi: 10.7759/cureus.62531
|
| 2 |
Neil C. Khoury, John W. Birk. A Review of IgG4-related Sclerosing Cholangitis (IgG4-SC). Journal of Clinical Gastroenterology 2024; 58(10) doi: 10.1097/MCG.0000000000001984
|
| 3 |
Louisa Tedesco, Syed B. Ali, Baran Erman, Safa Baris, Harshita Pant, Pravin Hissaria, Yelda Bilginer, Damon J. Tumes, Gökhan Cildir. IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy 2025; 80(10) doi: 10.1111/all.16686
|
| 4 |
Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM). eClinicalMedicine 2024; 70 doi: 10.1016/j.eclinm.2024.102526
|
| 5 |
Sayan Malakar, Sanjit Kumar, Akash Roy, Suprabhat Giri, Sumit Rungta, Mayank Agarwal, Amandeep Singh, Nitesh Bassi, Arghya Samanta, Uday C. Ghoshal, Virendra Singh. Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases. Journal of Clinical and Experimental Hepatology 2026; 16(4) doi: 10.1016/j.jceh.2026.103564
|
| 6 |
Kareem Khalaf, Natalia Causada Calo. Immunoglobulin G4–Related Sclerosing Cholangitis. Clinics in Liver Disease 2026; 30(3) doi: 10.1016/j.cld.2026.04.004
|
| 7 |
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Thoracoabdominal manifestations of immunoglobulin G4-related disease. Radiología (English Edition) 2023; 65(2) doi: 10.1016/j.rxeng.2022.06.005
|
| 8 |
Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera. Post-COVID-19 cholangiopathy: Systematic review. World Journal of Methodology 2023; 13(4): 296-322 doi: 10.5662/wjm.v13.i4.296
Abstract(1015) |
Core Tip(958) |
Full Article(HTML)(4640)
|
Full Article (PDF)-573K(303)
|
Full Article with Cover (PDF)-783K(252)
|
Full Article (Word)-231K(67)
|
Full Article (XML)-233K(185)
|
Audio-195K(20)
|
Peer-Review Report-218K(189)
|
Answering Reviewers-134K(196)
|
Times Cited (9)
|
Total Visits (6905)
|
Open
|
| 9 |
Sayan Malakar, Piyush Mishra, Radha Paturu, Ritu Verma, Uday C. Ghoshal. Primary sclerosing cholangitis with high immunoglobulin-G4. Journal of Hepatology 2024; 80(4) doi: 10.1016/j.jhep.2023.09.026
|
| 10 |
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6) doi: 10.1053/j.gastro.2021.07.046
|
| 11 |
Adrian C. Bateman, Emma L. Culver. Challenges and pitfalls in the diagnosis of IgG4-related disease. Seminars in Diagnostic Pathology 2024; 41(2) doi: 10.1053/j.semdp.2023.11.005
|
| 12 |
Jixuan Wang, Zhiwen Sun, Jingri Xie, Wanli Ji, Yang Cui, Zongxiong Ai, Guoying Liang. Inflammasome and pyroptosis in autoimmune liver diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1150879
|
| 13 |
Martin Cornillet, Aiva Lundberg Båve, Dan Sun, Ghada Nouairia, Christina Villard, Aristeidis Grigoriadis, Erik von Seth, Hannes Jansson, María Bueno Álvez, Sofia Bergström, Peter Nilsson, Mathias Uhlén, Fredrik Edfors, Per Stål, Mårten Werner, Nils Nyhlin, Fredrik Rorsman, Johan Vessby, Nilsson Emma, Antonio Molinaro, Annika Bergquist, Stergios Kechagias, Maria Antonella Burza, Lina Lindström, Ernesto Sparrelid, Niklas K. Björkström, Jonas Halfvarson, Annika Bergquist. Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations. JHEP Reports 2026; 8(3) doi: 10.1016/j.jhepr.2025.101719
|
| 14 |
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature. The American Journal of the Medical Sciences 2022; 364(3) doi: 10.1016/j.amjms.2022.04.016
|
| 15 |
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.07.005
|
| 16 |
Ruchika Goel, Chundamannil Eapen Eapen. Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(3) doi: 10.1016/j.jceh.2021.10.001
|
| 17 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 18 |
Bilal Ashraf, Dana Gornick, Wajeed Sumbal, Zainab Saeed, Ruben Peredo, Micheal Tadros. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025; doi: 10.1007/978-3-032-07868-1_10
|
| 19 |
Florian Fronhoffs, Leona Dold, Marijo Parčina, Arne Schneidewind, Maria Willis, Thomas F. E. Barth, Tobias J. Weismüller, Taotao Zhou, Philipp Lutz, Julian A. Luetkens, Peter Gerlach, Steffen Manekeller, Jörg C. Kalff, Tim O. Vilz, Christian P. Strassburg, Glen Kristiansen. Alveolar Echinococcosis in a Patient with Presumed Autoimmune Hepatitis and Primary Sclerosing Cholangitis: An Unexpected Finding after Liver Transplantation. Pathogens 2023; 12(1) doi: 10.3390/pathogens12010073
|
| 20 |
Aalam Sohal, Kris V. Kowdley. Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG Case Reports Journal 2024; 11(1) doi: 10.14309/crj.0000000000001256
|
| 21 |
Michele S. Barnhill, Channa Jayasekera. Secondary Sclerosing Cholangiopathies. Current Hepatology Reports 2024; 23(1) doi: 10.1007/s11901-024-00646-7
|
| 22 |
Mohammed Abdulrasak, Ali M. Someili, Mostafa Mohrag. Cytopenias in Autoimmune Liver Diseases—A Review. Journal of Clinical Medicine 2025; 14(5) doi: 10.3390/jcm14051732
|
| 23 |
Kathleen Möller, Barbara Braden, Emma L. Culver, Christian Jenssen, Ehsan Safai Zadeh, Amjad Alhyari, Christian Görg, André Ignee, Michael Hocke, Yi Dong, Siyu Sun, Siegbert Faiss, Christoph F. Dietrich. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging. Endoscopic Ultrasound 2023; 12(2) doi: 10.4103/EUS-D-22-00208
|
| 24 |
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Manifestaciones toracoabdominales de las enfermedades relacionadas con la inmunoglobulina G4. Radiología 2023; 65(2) doi: 10.1016/j.rx.2022.06.002
|
| 25 |
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies. Journal of Clinical Medicine 2024; 13(6) doi: 10.3390/jcm13061804
|
| 26 |
Tamsin Cargill, Eleanor Barnes, Theo Rispens, Emma L. Culver. The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosing Cholangitis and Its Relevance for Targeting B Cell Pathways in Disease. Biomedicines 2024; 12(12) doi: 10.3390/biomedicines12122839
|
| 27 |
Duygu Kirkik, Fatih Hacimustafaoglu, Barış Gündogdu, Betül Dogantekin, Mesut Kariksiz, Sevgi Kalkanli Tas. Genetic Susceptibility and Disease Activity in Ankylosing Spondylitis: The Role of G Protein-Coupled Receptor 35rs4676410 Polymorphism in a Turkish Population. Genetic Testing and Molecular Biomarkers 2025; 29(2) doi: 10.1089/gtmb.2024.0482
|
| 28 |
Dalal Sabbahia, Halima Msaaf, Meriem Atrassi, Sara Moukhlis, Nissrine Bennani, Abdelhak Abkari. IgG4 Sclerosing Cholangitis: Entity Rarely Described in Children
. American Journal of Pediatrics 2024; 10(3) doi: 10.11648/j.ajp.20241003.19
|
| 29 |
Henry H. Nguyen, Marvin J. Fritzler, Mark G. Swain. A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes. Frontiers in Molecular Medicine 2022; 2 doi: 10.3389/fmmed.2022.914505
|
| 30 |
Taotao Zhou, Henrike Lenzen, Leona Dold, Bennet Bündgens, Heiner Wedemeyer, Michael P. Manns, Maria A. Gonzalez‐Carmona, Christian P. Strassburg, Tobias J. Weismüller. Primary sclerosing cholangitis with moderately elevated serum‐IgG4 – characterization and outcome of a distinct variant phenotype. Liver International 2021; 41(12) doi: 10.1111/liv.15028
|
| 31 |
A. K. Guseva, A. V. Okhlobystin. Clinical Features, Differential Diagnosis and Treatment of IgG<sub>4</sub>-Related Sclerosing Cholangitis. The Russian Archives of Internal Medicine 2024; 14(2) doi: 10.20514/2226-6704-2024-14-2-96-107
|
| 32 |
Anthony Bedran, Karim Hoyek, Doha Houcheimy, Joanna Kreidi, Angelo Chami, Serena Nabhan, Karam Karam, Khalil Bedran. Autoimmune Biliary Diseases: From Fragmented Pathways to Precision Diagnosis. Sage Open Pathology 2026; 19 doi: 10.1177/30502098261472445
|
| 33 |
Daniel E. Radford‐Smith, Emmanuel A. Selvaraj, Rory Peters, Michael Orrell, Jonathan Bolon, Daniel C. Anthony, Michael Pavlides, Kate Lynch, Alessandra Geremia, Adam Bailey, Emma L. Culver, Fay Probert. A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis. Liver International 2022; 42(6) doi: 10.1111/liv.15192
|
| 34 |
O. V. Khlynova, P. V. Kosareva, D. S. Fadeev, L. V. Sivakova, E. I. Samodelkin. The role of B-lymphocytes and plasma cells in the pathogenesis of inflammatory bowel diseases. Experimental and Clinical Gastroenterology 2023; (6) doi: 10.31146/1682-8658-ecg-214-6-39-46
|
| 35 |
Sandra Kalthoff, Caroline Wolniak, Philipp Lutz, Christian P. Strassburg, Bettina Langhans, Leona Dold. Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03343-3
|
| 36 |
Bregje Mol, Ellen Werner, Emma L. Culver, Adriaan J. van der Meer, Johannes A. Bogaards, Cyriel Y. Ponsioen. Epidemiological and economical burden of cholestatic liver disease. Hepatology 2025; 82(4) doi: 10.1097/HEP.0000000000001341
|
| 37 |
Taotao Zhou, Florian Fronhoffs, Glen Kristiansen, Leona Dold, Dominik J. Kaczmarek, Christian P. Strassburg, Tobias J. Weismüller. Primary sclerosing cholangitis with IgG4‐positive plasma cells in bile duct biopsies ― Frequency and characterization. Journal of Digestive Diseases 2024; 25(6) doi: 10.1111/1751-2980.13295
|
| 38 |
Zhijie Lv, Li Wu, Yan Lu, Shan Liu, Qiushuang Li. Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection Databases. Clinical Rheumatology 2023; 42(1) doi: 10.1007/s10067-022-06377-8
|
| 39 |
Antonio M. Caballero-Mateos, Eduard Brunet-Mas, Beatriz Gros. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine 2025; 14(22) doi: 10.3390/jcm14227984
|
| 40 |
Sylvia Drazilova, Eduard Veseliny, Patricia Denisa Lenartova, Dagmar Drazilova, Jakub Gazda, Ivica Grgurevic, Martin Janicko, Peter Jarcuska, Yu-Chen Fan. IgG4‐Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/1959832
|
| 41 |
Miroslav Vujasinovic, Karouk Said, Christina Villard, Jennifer Carlsson, Christopher Poli, Patrick Maisonneuve, J.-Matthias Löhr. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis. Journal of Clinical Medicine 2023; 13(1) doi: 10.3390/jcm13010079
|
| 42 |
Aalam Sohal, Kris V. Kowdley. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert Opinion on Investigational Drugs 2024; 33(4) doi: 10.1080/13543784.2024.2330738
|